Evidence map›Paper›PMID 21859829›Full record

ArticleCancer research2011

Glioblastoma angiogenesis and tumor cell invasiveness are differentially regulated by β8 integrin.

Jeremy H Tchaicha, Steve B Reyes, Jaekyung Shin, Mohammad G Hossain, Frederick F Lang, Joseph H McCarty

Open access · greenAbstract read
In one paragraph

Article in Cancer research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 2 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 2 syntheses or guidelines pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Visualization of integrin molecules by fluorescence imaging and techniques.Biocell : official journal of the Sociedades Latinoamericanas de Microscopia Electronica ... et. al · 2021
    Article
  10. Non-Coding RNAs in Glioma Microenvironment and Angiogenesis.Frontiers in molecular neuroscience · 2021
    Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jeremy H TchaichaDepartment of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.
Steve B Reyes
Jaekyung Shin
Mohammad G Hossain
Frederick F Lang
Joseph H McCarty
The University of Texas MD Anderson Cancer Center · US

Funding

Tropism Enhanced Oncolytic Adenovirus for the Treatment of Brain TumorsP50CA127001 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Juan Fueyo · 2008 to 2026
$41.2M
Analysis of alphaVbeta8 Integrin In GliomagenesisR01NS059876 · NINDS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MCCARTY, JOSEPH H · 2008 to 2012
$1.9M
NCI NIH HHS P50 CA127001NCI NIH HHS P50CA127001-02NINDS NIH HHS R01 NS059876NINDS NIH HHS R01NS059876-03
6 · The paper itself

Abstract

Glioblastoma multiforme (GBM) is a highly invasive brain tumor that develops florid microvascular proliferation and hemorrhage. However, mechanisms that favor invasion versus angiogenesis in this setting remain largely uncharacterized. Here, we show that integrin β8 is an essential regulator of both GBM-induced angiogenesis and tumor cell invasiveness. Highly angiogenic and poorly invasive tumors expressed low levels of β8 integrin, whereas highly invasive tumors with limited neovascularization expressed high levels of β8 integrin. Manipulating β8 integrin protein levels altered the angiogenic and invasive growth properties of GBMs, in part, reflected by a diminished activation of latent TGFβs, which are extracellular matrix protein ligands for β8 integrin. Taken together, these results establish a role for β8 integrin in differential control of angiogenesis versus tumor cell invasion in GBM. Our findings suggest that inhibiting β8 integrin or TGFβ signaling may diminish tumor cell invasiveness during malignant progression and following antivascular therapies.

Indexed as

AnimalsBrain NeoplasmsCell Line, TumorExtracellular MatrixGlioblastomaHumansIntegrin beta ChainsMaleMiceMice, NudeNeoplasm InvasivenessNeovascularization, PathologicTransforming Growth Factor betaintegrin beta8Integrin beta ChainsTransforming Growth Factor beta

Identifiers

PMID21859829
PMCPMC3193578
OpenAlexW2122505281

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.